의료진 소개

박소정 교수
호흡기내과, 호흡기센터 관심의료진 등록
전문 진료 분야
중환자치료, 급성호흡곤란증후군, 패혈증, 만성폐쇄성 폐질환, 기관지확장증, 늑막질환 및 기타 폐질환, 코로나 후유증 클리닉
진료 일정
학력 및 경력사항
학력사항
- 울산대학교 의학박사
- 울산대학교 의학석사
- 인제대학교 의과대학 졸업
교육 및 연구경력
- 2021-현재 | 이대목동병원 호흡기내과 조교수
- 2019-2021 | 이대목동병원 호흡기내과 임상조교수
- 2018-2019 | 동탄성심병원 호흡기내과 임상조교수
- 2017-2018 | 서울아산병원 호흡기내과 임상전임강사
- 2016 | 미국 Yale School of Medicine laboratory associate
- 2015-2017 | 서울아산병원 호흡기내과 임상강사
- 2011-2015 | 서울아산병원 내과 전공의
- 2010-2011 | 서울아산병원 인턴
기타 학술 관련 경력
- 대한중환자의학회 평생회원
- 대한폐암학회 정회원
- 대한결핵및호흡기학회 정회원
- 대한내과학회 정회원
논문
- Risk factors for mortality among mechanically ventilated patients requiring pleural drainage. Int J Gen Med. 2022-02.
- Impact of COPD Treatment on Survival in Patients with Advanced Non-Small Cell Lung Cancer. Journal of Clinical Medicine. 2022, v.11 no.9, 2391.
- Stratifying non-small cell lung cancer patients using an inverse of the treatment decision rules: validation using electronic health records with application to an administrative database. BMC Medical Informatics and Decision Making. 2023, v.23 no.1, 3.
- Effectiveness of rapid response team on in-hospital mortality in patients with hematologic malignancy. Quality Improvement in Health Care. 2021.
- Effect of low protein intake on acute exacerbations in mild to moderate chronic obstructive pulmonary disease: data from the 2007-2012 KNHANES. J Thorac Dis. 2021-10.
- Comparison of epidermal growth factor receptor tyrosine kinase inhibitors for patients with lung adenocarcinoma harboring different epidermal growth factor receptor mutation types . BMC Cancer. 2021-01.
- Histologic features suggesting connective tissue disease in idiopathic pulmonary fibrosis. Sci Rep. 2020-12.
- Diagnostic yield of additional conventional transbronchial lung biopsy following radial endobronchial ultrasound lung biopsy for peripheral pulmonary lesions. Thorac Cancer. 2020-06.
- Clinical significance of EGFR mutation types in lung adenocarcinoma: A multi-centre Korean study. PLoS One . 2020-02.
- Tumor-derived exosomal miR-619-5p promotes tumor angiogenesis and metastasis through the inhibition of RCAN1.4. Cancer Letters. 2020-01.
- Effect of medical thoracoscopy-guided intrapleural docetaxel therapy to manage malignant pleural effusion in patients with non-small cell lung cancer: A pilot study. Thorac Cancer. 2019-10.
- CDK7 inhibition as a promising therapeutic strategy for lung squamous cell carcinomas with a SOX2 amplification. Cell Oncol . 2019-08.
- Risk factors associated with an increase in the size of ground glass lung nodules on chest computed tomography. Thorac Cancer. 2019-07.
- Exceptional pemetrexed sensitivity can predict therapeutic benefit from subsequent chemotherapy in metastatic non-squamous non-small cell lung cancer. J Cancer Research Clin Oncol. 2019-07.
- Survival benefit of first-generation epidermal growth factor receptor-tyrosine kinase inhibitors in female with advanced lung cancer. Tumori. 2019-06.
- Mobile phone app-based pulmonary rehabilitation for chemotherapy-treated patients with advanced lung cancer: Pilot study. JMIR Mhealth Uhealth. 2019-02.
- Chest radiography surveillance for lung cancer: Results from a National Health Insurance database in South Korea. Lung cancer. 2019-02.
- Mortality and Prognostic Prediction in Very Elderly Patients With Severe Pneumonia. J Intensive Care Med. 2019-01.
- Effect of vitamin D deficiency in Korean patients with acute respiratory distress syndrome. Korean J Intern Med. 2018-11.
- Non-small cell lung cancer with resistance to EGFR-TKI therapy: CT characteristics of T790M mutation-positive cancer. Radiology. 2018-10.
- Efficacy and safety of nintedanib in advanced idiopathic pulmonary fibrosis. Respir Res. 2018-10.
- Correlation between progression-free survival, tumor burden, and circulating tumor DNA in the initial diagnosis of advanced-stage EGFR-mutated non-small cell lung cancer. Thorac Cancer. 2018-09.
- In vitro MIC values of rifampin and ethambutol and treatment outcome in Mycobacterium avium complex lung disease. Antimicrob Agents Chemother. 2018-09.
- Clinical characteristics and treatment outcomes of pleural effusions in patients with nontuberculous mycobacterial disease. Respir Med . 2017-12.
- Assessment of EGFR mutation status using cell-free DNA from bronchoalveolar lavage fluid. Clin Chem Lab Med . 2017-08.
- Predictive factors for a long-term response duration in non-squamous cell lung cancer patients treated with pemetrexed. BMC cancer . 2016-07.
- Activation of the IGF1R pathway potentially mediates acquired resistance to mutant-selective 3rd-generation EGF receptor tyrosine kinase inhibitors in advanced non-small cell lung cancer . Oncotarget. 2016-04.
- Survival benefit of pemetrexed in lung adenocarcinoma patients with anaplastic lymphoma kinase gene rearrangements. Clin Lung Cancer . 2015-09.
- Comparison of LTBI treatment regimens for patients receiving anti-tumour necrosis factor therapy. Int J Tuberc Lung Dis . 2015-03.
언론 보도
- [헬스경향] 한번만 ‘콜록’해도 눈치…다 같은 기침 아니에요! 2020-04-23
- [중앙일보] [건강한 가족] 폐렴은 70세 이상 각종 질환자의 사망 원인 1위 2020-02-17